Evidence map›Paper›PMID 27771475›Full record

SynthesisContraception2017

The safety of intrauterine devices among young women: a systematic review.

Tara C Jatlaoui, Halley E M Riley, Kathryn M Curtis

Registry-linked trialOpen access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Contraception, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05875571 (Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement), which is not on this map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05875571 phase4unknown statusnot on this mapstarted 2024, after this paper: background citation

Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement: A Randomized, Double-Blind, Placebo-Controlled Trial

TypeinterventionalSponsorArkansas Children's Hospital Research InstituteRan2024 to 2025Enrolled18ConditionsIUD, Healthy Female, Contraception, IUD Insertion ComplicationArmsKetorolac, Placebo
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 183 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2021
    Guideline
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2023
    Article
  18. Migrated intrauterine device: Case series report.International journal of surgery case reports · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tara C JatlaouiDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: tjatlaoui@cdc.gov.
Halley E M RileyDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
Kathryn M CurtisDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
Centers for Disease Control and Prevention · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectiveThe objective was to determine the association between use of intrauterine devices (IUDs) by young women and risk of adverse outcomes.

methodsWe searched Pubmed, CINAHL, Embase, Popline and the Cochrane Library for articles from inception of database through December 2015. For outcomes specific to IUD use (IUD expulsion and perforation), we examined effect measures for IUD users generally aged 25 years or younger compared with older IUD users. For outcomes of pregnancy, infection, pelvic inflammatory disease (PID), and heavy bleeding or anemia, we examined young IUD users compared with young users of other contraceptive methods or no method.

resultsWe identified 3169 articles of which 16 articles from 14 studies met our inclusion criteria. Six studies (Level II-2, good to poor) reported increased risk of expulsion among younger age groups compared with older age groups using copper-bearing (Cu-) IUDs. Two studies (Level II-2, fair) examined risks of expulsion among younger compared with older women using levonorgestrel-releasing (LNG-) IUDs; one reported no difference in expulsion, while the other reported increased odds for younger women. Four studies (Level II-2, good to poor) examined risk of expulsion among Cu- and LNG-IUD users combined and reported no significant differences between younger and older women. For perforation, four studies (Level II-2, fair to poor) found very low perforation rates (range, 0%-0.1%), with no significant differences between younger and older women. Pregnancies were generally rare among young IUD users in nine studies (Level I to II-2, fair to poor), and no differences were reported for young IUD users compared with young combined oral contraceptive (COC) or etonogestrel (ENG) implant users. PID was rare among young IUD users; one study reported no cases among COC or IUD users, and one reported no difference in PID among LNG-IUD users compared with ENG implant users from nationwide insurance claims data (Level I to II-2, fair). One study reported decreased odds of bleeding with LNG-IUD compared with COC use among young women, while one study of young women reported decreased odds of removal for bleeding with LNG-IUD compared with ENG implant (Level I to II-2, fair).

conclusionOverall evidence suggests that the risk of adverse outcomes related to pregnancy, perforation, infection, heavy bleeding or removals for bleeding among young IUD users is low and may not be clinically meaningful. However, the risk of expulsion, especially for Cu-IUDs, is higher for younger women compared with older women. If IUD expulsion occurs, a young woman is exposed to an increased risk of unintended pregnancy if replacement contraception is not initiated. IUDs are safe for young women and provide highly effective reversible contraception.

Indexed as

Intrauterine Device ExpulsionIntrauterine Devices, CopperPregnancy, UnplannedAdolescentContraceptionContraceptive Agents, FemaleContraceptives, Oral, CombinedDesogestrelFemaleHumansLevonorgestrelPregnancyRandomized Controlled Trials as TopicRisk AssessmentYoung AdultContraceptive Agents, FemaleContraceptives, Oral, CombinedDesogestreletonogestrelLevonorgestrelAdolescentsIntrauterine deviceIUDLARCTeensYoung women

Identifiers

PMID27771475
PMCPMC6511984
OpenAlexW2532498648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.